Navigation Links
Human Genome Sciences Reports Positive Long-Term Data for LymphoStat-B in Patients With Active Systemic Lupus Erythematosus
Date:6/12/2008

l drugs to treat hepatitis C, lupus, inhalation anthrax, cancer and other immune-mediated diseases. The Company's primary focus is rapid progress toward the commercialization of its two key lead drugs, Albuferon(R) (albinterferon alfa- 2b) for hepatitis C and LymphoStat-B(R) (belimumab) for lupus. Phase 3 clinical trials of both drugs are ongoing.

ABthrax(TM) (raxibacumab) is in late-stage development for the treatment of inhalation anthrax, and the Company is on track to begin the delivery in fall 2008 of 20,000 doses of ABthrax to the Strategic National Stockpile under a contract entered into with the U.S. Government in June 2006. Other HGS drugs in clinical development include two TRAIL receptor antibodies and a small-molecule antagonist of IAP (inhibitor of apoptosis) proteins for the treatment of cancer. In addition, HGS has substantial financial rights to three products in the GlaxoSmithKline clinical development pipeline.

To view the EULAR oral presentation reporting results of the Phase 2 long- term continuation study of LymphoStat-B through three years, click here. To view the EULAR poster presentation reporting the safety profile of LymphoStat- B through three years, click here. To view the EULAR poster presentation reporting the progressive normalization of autoantibody, immunoglobulin and complement levels over three years of treatment with LymphoStat-B, click here. To view the EULAR poster presentation reporting evidence of LymphoStat-B's potential steroid-sparing activity, click here. For more information on LymphoStat-B, visit http://www.hgsi.com/belimumab.html. For more information on lupus, visit the Lupus Foundation of America at http://www.lupus.org or the European Lupus Erythematosus Federation at http://www.elef.rheumanet.org . For more information about HGS, visit
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability
2. Human Genome Sciences Initiates First Clinical Trial of Lead IAP Inhibitor HGS1029 in Advanced Solid Tumors
3. Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives
4. Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials
5. St. Jude Finds Dancing Hair Cells Are Key to Humans Acute Hearing
6. Increases in West Nile Virus Replikin Concentrations Precede Increases in the Number of Human Cases
7. Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics Heart Health Test
8. Quantum Immunologics, Inc. and the South Alabama Medical Science Foundation Announce an Early Clinical Evaluation of a Novel Immuno-therapeutic Vaccine for Treating Advanced Human Breast Carcinomas
9. First Human Implant of New Archus Orthopedics Facet Replacement System
10. Human Genome Sciences Completes Enrollment in First of Two Phase 3 Lymphostat-B(R) Trials
11. Tepha Announces First Human Usage of Medical Devices Derived from New Class of Resorbable Polymers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... , Dec. 17, 2014  ImmunoCellular Therapeutics, Ltd. ... Patent and Trademark Office (USPTO) has issued a ... dendritic cell-based immunotherapeutic vaccine targeting six tumor antigens ... of US Patent No. 8,871,211, which issued October ... by administering a dendritic cell composition comprising peptide ...
(Date:12/17/2014)... RALEIGH, N.C. , Dec. 17, ... (CTMC), and Integrated Clinical Trial Services, LLC (ICTS), ... for clinical trials announce that they have formed ... Services (i-CTMS). i-CTMS will provide a broad range ... biotechnology and medical device companies. i-CTMS ...
(Date:12/15/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/vt6973/mems_gyroscopes ) ... Gyroscopes Analog Devices ADIS16136 Precision Angular Rate Sensor ... http://photos.prnewswire.com/prnh/20130307/600769 ... a lot of progress in the past few ... accepted in high-reliability environments, and are even starting ...
Breaking Medicine Technology:ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine 2Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 2Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 3MEMS Gyroscopes Analog Devices ADIS16136 Precision Angular Rate Sensor Reverse Costing Analysis 2
... Ikaria Holdings, Inc. today announced that it has been ... by the New Jersey Business & Industry Association (NJBIA), ... Ikaria earned the award based on criteria including ... creation of new jobs. , "We are delighted that ...
... 21 PharmaNet Development Group, Inc., a leading provider ... and medical device companies, today announced its participation at ... place at the World Trade Center in Rotterdam, The ... the conference, top management will discuss some of the ...
Cached Medicine Technology:Ikaria Receives Award for Excellence by New Jersey Business & Industry Association 2PharmaNet Development Group Management Participates in the 8th Annual Partnerships in Clinical Trials Conference in Rotterdam 2
(Date:12/17/2014)... By Alan Mozes ... -- With the holiday party season fast approaching, a new ... and make DUI arrests have fewer drunk drivers on their ... driving laws more vigilantly are better able to deter inebriated ... "Hardly any new laws are being passed regarding drinking ...
(Date:12/15/2014)... 15, 2014 Cancer researchers have just ... genetic causes of deadly malignant pleural mesothelioma. Surviving Mesothelioma ... their website. Click here to read it now. ... Hawaii Cancer Center, and New York’s Langone Medical Center ... mesothelioma patients in an effort to pinpoint the ...
(Date:12/15/2014)... SIMpalm, a leading mobile app development company ... its client, which allows users to keep track of ... finding the right wine. At the center of ... chemistry and wine information. All this information is assembled ... wines that are close counterparts to one another are ...
(Date:12/15/2014)... News) -- Expert pilots process visual information more efficiently ... better decisions during landings, a new study shows. ... pilots to master, and 36 percent of all airplane ... final approach and landing. Researchers monitored the brain ... pilots while they were at the controls of a ...
(Date:12/15/2014)... In support of high-quality independent ... restrictive state laws that may have unintended consequences ... area of public health policy. , The position ... of Independent Review, contends that state legislation that ... review determinations can result in subpar outcomes for ...
Breaking Medicine News(10 mins):Health News:Enforcement of Drunk Driving Laws Makes Roads Safer, Study Finds 2Health News:Enforcement of Drunk Driving Laws Makes Roads Safer, Study Finds 3Health News:New Study Reveals Genetic Mutations That May Trigger Mesothelioma, According to Surviving Mesothelioma 2Health News:Use WinMatch Connect App to Keep Track of Wines You Like 2Health News:Study Shows Why Expert Pilots Are Experts 2Health News:NAIRO Calls for Higher Quality Independent Peer Review By Ending Restrictive State Laws 2
... The National AIDS Fund (NAF) in,Washington, D.C., ... expanding,network of Community Partnerships that support over ... marketing agency, HGX Creative,to spearhead its branding ... National, Community Partnerships and Individual Consumer,Marketing., ...
... Join Forces - Urge Reinvestment of Billions into Medicare,Program, ... of the State of New York, and StateWide Senior ... Schumer to lead the U.S. Senate in,strengthening Medicare by ... premiums, and helping lower income,persons pay for prescription drugs. ...
... and close friend,Lejon Boudreaux, along with world-renowned, ultra-marathoner Dean Karnazes,have ... staging a run,from San Francisco to Los Angeles. The 510-mile ... and end two weeks later on Dec. 14, 2007. At,the ... variety of local,activities. The trip will be chronicled via writings ...
... Healthcare,Foundation (AHF) will provide $100,000 in initial in-kind services ... Initiative announced this morning in Los Angeles and New ... covering the salary of a full-time, citywide coordinator ... -- Spearheading and financing a Public Policy component ...
... little of nutrients that cut their odds for malignancy, study finds ... for women in America,s inner cities to eat in ways that ... Hopkins University study that looked at the dietary habits of 156 ... , The researchers found that about 61 percent of the women ...
... 30 SuperArray Bioscience,Corporation announced today that ... license agreement with The Carnegie Institution. Under ... and,distribute worldwide RNA interference based gene function ... agreement enables SuperArray to offer RNAi-based gene ...
Cached Medicine News:Health News:HGX Selected as Creative Agency for National AIDS Fund New Brand 2Health News:HGX Selected as Creative Agency for National AIDS Fund New Brand 3Health News:Groups Call On Senator Charles Schumer to Lead Senate In Strengthening Medicare 2Health News:Groups Call On Senator Charles Schumer to Lead Senate In Strengthening Medicare 3Health News:Run-in-a-Million Run from San Francisco to Los Angeles to Raise Awareness About AIDS and HIV Testing 2Health News:AIDS Healthcare Foundation's Role in the City of Los Angeles' HIV Testing Initiative 2Health News:Diets May Raise Cancer Risk for Poor, Urban Women 2Health News:SuperArray Bioscience Corporation Licenses RNA Interference Patent From The Carnegie Institution 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: